193 related articles for article (PubMed ID: 25087510)
1. Mechanistic basis for functional promiscuity in the TNF and TNF receptor superfamilies: structure of the LIGHT:DcR3 assembly.
Liu W; Zhan C; Cheng H; Kumar PR; Bonanno JB; Nathenson SG; Almo SC
Structure; 2014 Sep; 22(9):1252-1262. PubMed ID: 25087510
[TBL] [Abstract][Full Text] [Related]
2. Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3.
Liu W; Ramagopal U; Cheng H; Bonanno JB; Toro R; Bhosle R; Zhan C; Almo SC
Structure; 2016 Nov; 24(11):2016-2023. PubMed ID: 27806260
[TBL] [Abstract][Full Text] [Related]
3. Decoy strategies: the structure of TL1A:DcR3 complex.
Zhan C; Patskovsky Y; Yan Q; Li Z; Ramagopal U; Cheng H; Brenowitz M; Hui X; Nathenson SG; Almo SC
Structure; 2011 Feb; 19(2):162-71. PubMed ID: 21300286
[TBL] [Abstract][Full Text] [Related]
4. Shining LIGHT on functional promiscuity in the TNF and TNFR superfamilies.
Whalen DM; Hymowitz SG
Structure; 2014 Sep; 22(9):1221-1222. PubMed ID: 25185824
[TBL] [Abstract][Full Text] [Related]
5. Polymorphic variants of LIGHT (TNF superfamily-14) alter receptor avidity and bioavailability.
Cheung TC; Coppieters K; Sanjo H; Oborne LM; Norris PS; Coddington A; Granger SW; Elewaut D; Ware CF
J Immunol; 2010 Aug; 185(3):1949-58. PubMed ID: 20592286
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and structural characterization of the human TL1A ectodomain.
Zhan C; Yan Q; Patskovsky Y; Li Z; Toro R; Meyer A; Cheng H; Brenowitz M; Nathenson SG; Almo SC
Biochemistry; 2009 Aug; 48(32):7636-45. PubMed ID: 19522538
[TBL] [Abstract][Full Text] [Related]
7. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis.
Yu KY; Kwon B; Ni J; Zhai Y; Ebner R; Kwon BS
J Biol Chem; 1999 May; 274(20):13733-6. PubMed ID: 10318773
[TBL] [Abstract][Full Text] [Related]
8. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.
Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M
Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906
[TBL] [Abstract][Full Text] [Related]
9. DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression.
Zhang H; Chen X; Li D; Cui L; Li X; Ye X; Wan X
Oncol Rep; 2017 Jul; 38(1):377-383. PubMed ID: 28560426
[TBL] [Abstract][Full Text] [Related]
10. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
Lin WW; Hsieh SL
Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
[TBL] [Abstract][Full Text] [Related]
11. DcR3 protects islet beta cells from apoptosis through modulating Adcyap1 and Bank1 expression.
Han B; Wu J
J Immunol; 2009 Dec; 183(12):8157-66. PubMed ID: 20007581
[TBL] [Abstract][Full Text] [Related]
12. Creation of a LIGHT mutant with the capacity to evade the decoy receptor for cancer therapy.
Morishige T; Yoshioka Y; Inakura H; Tanabe A; Yao X; Tsunoda S; Tsutsumi Y; Mukai Y; Okada N; Nakagawa S
Biomaterials; 2010 Apr; 31(12):3357-63. PubMed ID: 20117833
[TBL] [Abstract][Full Text] [Related]
13. DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts.
Takahashi M; Miura Y; Hayashi S; Tateishi K; Fukuda K; Kurosaka M
Int J Mol Med; 2011 Sep; 28(3):423-7. PubMed ID: 21537832
[TBL] [Abstract][Full Text] [Related]
14. The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases.
Siakavellas SI; Sfikakis PP; Bamias G
Semin Arthritis Rheum; 2015 Aug; 45(1):1-8. PubMed ID: 25887448
[TBL] [Abstract][Full Text] [Related]
15. Proinflammatory effects of LIGHT through HVEM and LTbetaR interactions in cultured human umbilical vein endothelial cells.
Chang YH; Hsieh SL; Chao Y; Chou YC; Lin WW
J Biomed Sci; 2005; 12(2):363-75. PubMed ID: 15917993
[TBL] [Abstract][Full Text] [Related]
16. Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT.
Wroblewski VJ; Witcher DR; Becker GW; Davis KA; Dou S; Micanovic R; Newton CM; Noblitt TW; Richardson JM; Song HY; Hale JE
Biochem Pharmacol; 2003 Feb; 65(4):657-67. PubMed ID: 12566095
[TBL] [Abstract][Full Text] [Related]
17. Molecular cloning and characterization of TNFSF14 (LIGHT) and its receptor TNFRSF14 (HVEM) in guinea pig (Cavia porcellus).
Li C; Chen S; Song J; Liu H; Gu W; Ai H; Zhao B; Zhang S
Gene; 2013 Sep; 526(2):374-84. PubMed ID: 23732292
[TBL] [Abstract][Full Text] [Related]
18. Creation of a lysine-deficient LIGHT mutant with the capacity for site-specific PEGylation and low affinity for a decoy receptor.
Morishige T; Yoshioka Y; Inakura H; Tanabe A; Yao X; Tsunoda S; Tsutsumi Y; Mukai Y; Okada N; Nakagawa S
Biochem Biophys Res Commun; 2010 Mar; 393(4):888-93. PubMed ID: 20175993
[TBL] [Abstract][Full Text] [Related]
19. Differential cellular expression of LIGHT and its receptors in early gestation human placentas.
Gill RM; Coleman NM; Hunt JS
J Reprod Immunol; 2007 Jun; 74(1-2):1-6. PubMed ID: 17010447
[TBL] [Abstract][Full Text] [Related]
20. Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action.
Yang CR; Hsieh SL; Teng CM; Ho FM; Su WL; Lin WW
Cancer Res; 2004 Feb; 64(3):1122-9. PubMed ID: 14871847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]